Why was the Dangerous and Contagious FluMist Vaccine Approved by the CDC?

In February 2018, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to re-recommend the live virus nasal spray influenza vaccine, FluMist, for the 2018-19 “flu season” after a two-year hiatus. The live attenuated influenza vaccine (LAIV) is popular, particularly with children, since it is sprayed up the nose and does not require a needle for administration. The ACIP voted against recommending the quadrivalent FluMist for the 2016-17 and 2017-18 influenza seasons due to the vaccine’s ineffectiveness in protecting against the H1N1 strain (Influenza A). It is important to note that there are cases reported in the medical literature that FluMist has resulted in shedding and transmission of vaccine strain influenza virus. Despite the fact that the efficacy and effectiveness of this vaccine is unknown, Cynthia Pellegrini, senior vice president of public policy and government affairs for March of Dimes stated, “This vaccine is better than not being vaccinated and there are kids who will not be vaccinated without this option…” The assumption that using FluMist is better than not being vaccinated given the lack of data on the efficacy is not rational because it is not based on scientific evidence.

CDC Scandal: Committee that Withdrew Recommendation for Nasal Flu Vaccine Now Recommends it to Experiment on American Public

In June of 2016 the Center for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) admitted that the live attenuated nasal influenza vaccine known as “FluMist” was not effective, and was not recommended for the 2016-2017 flu season. It was also not recommended for the current flu season (2017-2018). The CDC's own data showed that the nasal vaccine was not effective. The CDC press release in 2016 stated, “This three percent estimate means no protective benefit could be measured.” Shortly after this announcement in 2016, a family in Utah went public with their story, explaining how their 8-year old daughter died from influenza, even though she had been vaccinated with FluMist. They had trusted the CDC and their flu recommendations, but now they have lost their daughter. Even though the CDC withdrew their recommendation for the failed nasal flu vaccine, FluMist retained its FDA approval and has been available to purchase the past two years. On February 21, 2018, the CDC's ACIP reversed its decision on FluMist, and voted 12-2 to add FluMist to the CDC’s list of recommended vaccines for the 2018-2019 influenza season. Stat News reports how members of the ACIP expressed concerns about deciding to reverse their decision and recommend it: "The motion to recommend FluMist passed by a surprising 12-to-2 vote, the outcome of which belies the unease that a number of members of the committee clearly felt about the decision they were making. They faced, in essence, a Catch-22: It has been impossible to generate the type of data that would normally be used to make a decision like this. The only way to see if the problem has been solved is to use the vaccine. But without an ACIP recommendation, the vaccine’s use in the U.S. would remain minimal." So the fact is that the effectiveness of FluMist is still not known, but the CDC has no qualms about testing it on the American public to find out.

New Study Proposes Self-administered Flu Vaccine Without Doctor Supervision

by Dr. Sherri Tenpenny
Facebook Page

Great! Hand out a vial so everyone can squirt live viruses up your nose, including all the 0.2mg of MSG, […]